VU LSC-EMBL Partnership for Genome Editing Technologies

EMBL and VU LSC, recognising the scientific and technological potential of uniting their complementary strengths in the field of targeted genome modification, decided to intensify existing links and build further institutional synergies by creating the Partnership for Genome Editing Technologies.

Molecular insights into intra-complex signal transmission during stressosome activation

MIMS Symposium 2022: a platform for showcasing collaboration in basic, translational and clinical research

partnerships Archives, Page 2 of 9

Seminars at LSC

The Partnership Institute of the European Molecular Biology Laboratory to Open at VU LSC

Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling, Cellular & Molecular Biology Letters

The Partnership Institute of the European Molecular Biology Laboratory to Open at VU LSC

Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors - ScienceDirect

RCSB PDB - 7LYT: Cryo-EM structure of CasPhi-2 (Cas12j) bound to crRNA and Phosphorothioate-DNA

VU Life Sciences Center and EMBL Partnership - Pursuing New Genome Editing Technologies And Applications